Donepezil enhances frontal functional connectivity in Alzheimer's Disease: a pilot study

Donepezil enhances frontal functional connectivity in Alzheimer's Disease: a pilot study

<p>Background: We have previously shown that increased resting-state functional magnetic resonance imaging (fMRI)-based functional connectivity (FC) within the frontal resting-state networks in Alzheimer's disease (AD) patients reflects residual, possibly compensatory, function. This sugg...

Detaylı Bibliyografya
Asıl Yazarlar:	Griffanti, L, Wilcock, G, Voets, N, Bonifacio, G, Mackay, C, Jenkinson, M, Zamboni, G
Materyal Türü:	Journal article
Baskı/Yayın Bilgisi:	Karger Publishers Open Access 2016

Benzer Materyaller

Donepezil Enhances Frontal Functional Connectivity in Alzheimer's Disease: A Pilot Study
Yazar:: Ludovica Griffanti, ve diğerleri
Baskı/Yayın Bilgisi: (2016-10-01)

Resting functional connectivity reveals residual functional activity in Alzheimer's disease.
Yazar:: Zamboni, G, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Resting functional connectivity reveals residual functional activity in Alzheimer's disease
Yazar:: Zamboni, G, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Donepezil for the treatment of agitation in Alzheimer's disease.
Yazar:: Howard, R, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Resting functional connectivity reveals residual functional activity in Alzheimer's disease.
Yazar:: Zamboni, G, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

A long-term comparison of galantamine and donepezil in the treatment of Alzheimer's disease.
Yazar:: Wilcock, G, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

A long-term comparison of galantamine and donepezil in the treatment of moderate-to-severe Alzheimer's disease: An intent-to-treat analysis
Yazar:: Wilcock, G, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Galantamine vs donepezil in the treatment of Alzheimer's disease.
Yazar:: Goldlist, B, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Modulation of Brain Activity and Functional Connectivity by Acupuncture Combined With Donepezil on Mild-to-Moderate Alzheimer's Disease: A Neuroimaging Pilot Study
Yazar:: Yijun Zhan, ve diğerleri
Baskı/Yayın Bilgisi: (2022-07-01)

Contributors to white matter damage in the frontal lobe in Alzheimer's disease.
Yazar:: Chalmers, K, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Donepezil for dementia due to Alzheimer's disease
Yazar:: Birks, J, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Donepezil Treatment for Alzheimer’s Disease in Chronic Dialysis Patients
Yazar:: Konstantina G. Yiannopoulou, ve diğerleri
Baskı/Yayın Bilgisi: (2019-09-01)

Monoaminergic innervation of the frontal and temporal lobes in Alzheimer's disease.
Yazar:: Palmer, A, ve diğerleri
Baskı/Yayın Bilgisi: (1987)

Donepezil and memantine for moderate-to-severe Alzheimer's disease
Yazar:: Howard, R, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Frontal cortical synaptophysin in Lewy body diseases: relation to Alzheimer's disease and dementia.
Yazar:: Hansen, L, ve diğerleri
Baskı/Yayın Bilgisi: (1998)

Neuroanatomy of impaired self-awareness in Alzheimer's disease and mild cognitive impairment.
Yazar:: Zamboni, G, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Neuroanatomy of impaired self-awareness in Alzheimer's disease and mild cognitive impairment
Yazar:: Zamboni, G, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Donepezil improves vascular function in a mouse model of Alzheimer’s disease
Yazar:: Carolina Pellegrini, ve diğerleri
Baskı/Yayın Bilgisi: (2021-12-01)

Discontinuing Donepezil or Starting Memantine for Alzheimer's Disease Reply
Yazar:: Howard, R, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Clinical Assessment of Alzheimer’s Disease and Response to Donepezil Treatment
Yazar:: Serge Gauthier
Baskı/Yayın Bilgisi: (2020-12-01)

MMP-3 and-9 may degrade the perineuronal net but their activity is not increased in frontal cortex in Alzheimer's disease
Yazar:: Baig, S, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Donepezil: A meta-analysis of individual patient data from randomized controlled trials in the treatment of patients with mild to moderate Alzheimer's disease.
Yazar:: Pratt, R, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Donepezil: A meta-analysis of individual patient data from randomized controlled trials in the treatment of patients with mild to moderate Alzheimer's disease.
Yazar:: Perdomo, C, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Donepezil: A meta-analysis of individual patient data from randomized controlled trials in the treatment of patients with mild to moderate Alzheimer's disease
Yazar:: Wilcock, G, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Donepezil for the symptomatic treatment of patients with mild to moderate Alzheimer's disease: a meta-analysis of individual patient data from randomised controlled trials.
Yazar:: Whitehead, A, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Research progress of donepezil for treating mild to moderate Alzheimer's disease
Yazar:: Xin-xin LI, ve diğerleri
Baskı/Yayın Bilgisi: (2017-02-01)

Aberrant functional connectivity within the basal ganglia of patients with Parkinson's disease
Yazar:: Michal Rolinski, ve diğerleri
Baskı/Yayın Bilgisi: (2015-01-01)

Structural MRI changes detectable up to ten years before clinical Alzheimer's disease
Yazar:: Tondelli, M, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Structural MRI changes detectable up to ten years before clinical Alzheimer's disease.
Yazar:: Tondelli, M, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Peran donepezil dalam terapi penyakit alzheimer
Yazar:: Perpustakaan UGM, i-lib
Baskı/Yayın Bilgisi: (1999)

Obsessive–compulsive disorder induced by donepezil in a patient with Alzheimer's disease
Yazar:: Kohei Echizen, ve diğerleri
Baskı/Yayın Bilgisi: (2024-06-01)

Evaluation the effect of Donepezil on Cerebral Blood Flow Velocity in Alzheimer's Disease
Yazar:: Abbas Ghorbani, ve diğerleri
Baskı/Yayın Bilgisi: (2010-11-01)

Safety and tolerability of donepezil 23 mg in moderate to severe Alzheimer's disease
Yazar:: Zou Heng, ve diğerleri
Baskı/Yayın Bilgisi: (2011-05-01)

Multi-target directed donepezil-like ligands for Alzheimer's disease
Yazar:: Mercedes eUnzeta, ve diğerleri
Baskı/Yayın Bilgisi: (2016-05-01)

Donepezil + chromone + melatonin hybrids as promising agents for Alzheimer’s disease therapy
Yazar:: Irene Pachón-Angona, ve diğerleri
Baskı/Yayın Bilgisi: (2019-01-01)

Effect of Donepezil and Hyoscyamoside on Improving Spatial Memory in Rats With Alzheimer\'s Disease
Yazar:: Fatemeh Heidari Soureshjani, ve diğerleri
Baskı/Yayın Bilgisi: (2020-09-01)

The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease
Yazar:: E Loveman, ve diğerleri
Baskı/Yayın Bilgisi: (2006-01-01)

Donepezil plus memantine versus donepezil alone for treatment of concomitant Alzheimer’s disease and chronic obstructive pulmonary disease: a retrospective observational study
Yazar:: Yangyi Cao, ve diğerleri
Baskı/Yayın Bilgisi: (2020-02-01)

Donepezil Does Not Enhance Perceptual Learning in Adults with Amblyopia: A Pilot Study
Yazar:: Susana T. L. Chung, ve diğerleri
Baskı/Yayın Bilgisi: (2017-08-01)

Comparative Study of Donepezil-Loaded Formulations for the Treatment of Alzheimer’s Disease by Nasal Administration
Yazar:: Lupe Carolina Espinoza, ve diğerleri
Baskı/Yayın Bilgisi: (2022-11-01)